$IVOB to Penetrate World Market with PREGNANT PROFITS!!!

August 21st, 2009 at 6:40 am Posted by The Dean

The Dean is very excited about $IVOB especially after meeting with CEO Katie Karloff in Boston yesterday.

INVO Bioscience (OTCBB: IVOB) is the biotechnology genius behind the patented INVOcell infertility treatment device and the INVO FRANCHISE!

The Dean was quite impressed with $IVOB before but now he’s even more ecstatic to learn about $IVOB‘s developments and plans for the future directly from the source!

Both $IVOB and The Dean think their INVO BRAND will be successful because their INVOcell device has the potential to deliver a cost-effective infertility solution to a HUGE MARKET! And because $IVOB‘s patented product is a more natural method of in vitro fertilization (IVF) it’s appealing to patients and investors!

Former Boston Scientific (NYSE: BSX) Director of Operations turned $IVOB CEO Katie Karloff is pretty confident that $IVOB is capable of a lot MORE with a lot LESS people! Karloff worked her way up at Boston Scientific (NYSE: BSX) over the course of 13 years and was instrumental in taking the company from an operation with less than 100 employees and $1 million a month in sales to a $30 billion company with 13,000 employees!

The Dean believes that Karloff has already started using her VALUABLE experience working for the biggest medical device company in the world to bring $IVOB public and turn the INVO FRANCHISE into a reality!

The Dean was also excited to learn that Dr. Claude Ranoux, developer of the INVOcell and INVO Procedure, is a pioneer of intra vaginal cultures which harvests the BEST embryos for IVF! And The Dean believes that the 8 years that went into the perfection of the INVOcell will be worth every penny.

In the Boston area, it seems like The Dean isn’t the only one drafting Ivy League Picks because $IVOB plans to acquire two HEAVY HITTERS to beef up their marketing lineup and The Dean will make sure to keep his students posted when the $IVOB team EXPANDS!

$IVOB has already begun building franchises and 7 COUNTRIES are already using their INVOcell device. Dr. Ranoux is currently in South America training 17 physicians, which will MORE THAN TRIPLE the number of centers using the INVO procedure in the world!

The Dean has done his homework and thinks that $IVOB could reap HEAVY PROFITS with their more accessible and less expensive INVO Procedure.

While meeting with $IVOB‘s CEO, The Dean learned of the $6 million projection for 2010! And that’s without FDA approval and the American, Chinese and Japanese markets!

Currently there’s 150 million infertile couples in the world. If $IVOB treats just 1% of the infertile population, they could see $500 million in revenues! And $IVOB‘s goal is to treat 5%, making that figure closer to a $2.5 billion estimate!

If that happens, The Dean figures a 20 P/E would call for a POTENTIAL BUYOUT of at least $2 billion. That means $IVOB could GROW to $30 to $40 PER SHARE! With $IVOB trading around $0.26 now, investors could gain an 11,000% PROFIT—and that’s on the LOW side!